While the mechanisms by which diabetes affects the advancement and treatment response of lung cancer are still unclear, increasing evidence suggests that diabetes can promote cancer through factors such as hyperglycemia, insulin resistance, hyperinsulinemia, insulin-like growth factor (IGF) expression, immune damage, and reactive oxygen species (ROS) production [10, 11]. The gene discussed is IGF1; the disease is diabetes mellitus.